Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic Leukemia. Pasupuleti SK, Ramdas B, Padam KSR, Kanumuri R, et al. Blood 2026 Jun 2:blood.2025032588. doi: 10.1182/blood.2025032588.

Read + Share

Amedeo Smart

Independent Medical Education

Pasupuleti SK, Ramdas B, Padam KSR, Kanumuri R, et al. Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic Leukemia. Blood 2026 Jun 2:blood.2025032588. doi: 10.1182/blood.2025032588.
PMID: 42233403